PT Diastika Biotekindo Tbk

CHEK · JK · Healthcare / Medical Distribution

102.00IDR+1.00 (+0.99%)

Price History

Full chart

Market Stats

Previous Close101.00

Open102.00

Day Range101.00 – 103.00

52-Week Range111.00 – 196.00

Volume301.20K

Market Cap485.37B

P/E (TTM)0.00

Forward P/E0.00

Dividend Yield0.00%

50-Day Avg131.48

200-Day Avg137.35

About

PT Diastika Biotekindo Tbk engages in the sale of disposable or consumable medical goods and diagnostic equipment in Indonesia. It operates through Clinical Diagnostic Group and Life Science Group segments. The company offers various products for detecting, diagnosing, and monitoring human disease. It also provides life science products that are processed from biological products. In addition, the company engages in general trading, laboratory equipment, research, medicine, export and import, pharmaceutical chemicals, services, electronics, and industrial activities. PT Diastika Biotekindo was founded in 1989 and is headquartered in Jakarta Timur, Indonesia. PT Diastika Biotekindo Tbk is a subsidiary of PT Optel Investama Mulia.

Company Details

SectorHealthcare
IndustryMedical Distribution
CEOMr. Franciscus Xaverius Yoshua Raintjung
Employees123
HeadquartersJalan Rawa Gelam V Block L, Jakarta Timur, Indonesia, 13930, Indonesia
Websitehttps://diastika.co.id

Leadership

Mr. Franciscus Xaverius Yoshua RaintjungPresident Director · b. 1979
Muliyati SHead of Finance
Ricki BudimanGeneral Manager of Operational
. TyasLegal Manager
Randi GuntaraMarketing Manager
Ms. Marcella AngelinFinance Director & Director · b. 1987
Mr. Jeremiah Warren PiskunovHead of Internal Audit · b. 1997
Muhammad Julyana AgustiarCorporate Secretary

Financials

Income Statement

Currency: IDR	2023-12-31	2024-12-31	2025-12-31
Total Revenue	129.10B	154.79B	201.31B
Growth (%)	-	+19.90%	+30.05%
Cost of Revenue	79.51B	94.07B	124.17B
Gross Profit	49.59B	60.72B	77.14B
Gross Margin	38.41%	39.23%	38.32%
Operating Expense	34.31B	39.22B	53.99B
Operating Income	15.28B	21.49B	23.15B
Operating Margin	11.83%	13.89%	11.50%
Net Income	13.59B	15.17B	14.02B
Net Income Margin	10.53%	9.80%	6.97%

Balance Sheet

Currency: IDR	2023-12-31	2024-12-31	2025-12-31
Total Assets	97.49B	118.81B	259.53B
Total Liabilities	19.24B	25.57B	48.45B
Total Equity	78.26B	93.24B	211.08B
Cash	20.08B	17.82B	18.81B

Cash Flow

Currency: IDR	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	19.39B	13.04B	-43.15B
Investing Cash Flow	-12.97B	-15.20B	-27.27B
Financing Cash Flow	-5.83B	-153.99M	121.43B
Capital Expenditure	16.11B	15.21B	28.44B
Dividends Paid	-	-	3.30B

Key Statistics & Ratios

Market Cap485.37B

Enterprise Value542.96B

Trailing P/E0.00

Forward P/E0.00

Price / Sales2.36

Price / Book0.00

Book Value50.23

Revenue (TTM)205.27B

Gross Profit (TTM)78.03B

EBITDA33.82B

Profit Margin5.98%

Operating Margin7.01%

Return on Equity8.24%

Return on Assets5.99%

Shares Outstanding4.11B

Shares Float782.43M

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%